To The Moon

$SPDR S&P 500 ETF Trust(SPY)$  major pivot $740. previous resistance, new support on the week

$SPDR S&P 500 ETF Trust(SPY)$ $Invesco QQQ(QQQ)$ $iShares Russell 2000 ETF(IWM)$ $Moderna, Inc.(MRNA)$ It's moving up quite a bit.

$Spdr S&P Biotech Etf(XBI)$ The monthly chart for XBI looks like a work of art. Filling that gap at $174.79 seemed impossible six months ago, but it feels more like an inevitability now. The tough part with biotech is the classic cycle: years of underperformance against the SPY, followed by parabolic gains that hit all at once. Market irrationality tends to overshoot in both directions. So I wouldn't be surprised if XBI breaks $180 at some point this year, especially with the persistently high short interest that could force some buying.

$Invesco QQQ(QQQ)$ Monday calls on $SPDR S&P 500 ETF Trust(SPY)$  are looking good.

$Invesco QQQ(QQQ)$ The options chain for $SELLAS Life Sciences Group Inc.(SLS)$  looks unusual. The Jan '27 $20 calls are priced at $6.20, while the Jan '27 $30 calls are at $4.70. That's only a $1.50 premium for a strike that's $10 lower, which isn't typical for a standard options chain. It seems the market is assigning significant value to upside and pricing in substantial volatility on the longer-dated curve. This is alongside around 63 million shares sold short, elevated borrow fees, substantial call open interest, and a key biotech catalyst ahead. To me, this combination suggests something significant is being priced in. For those short, the setup could become costly if their thesis doesn't h

$SELLAS Life Sciences Group Inc.(SLS)$ OBV and RSI on the quarterly chart still clearly show where it's heading.

The US session handed Asia a clean bid — ES up 42 handles, with NQ carrying the load at +422. VIX backed off to 16.45, so the vol market is confirming the move rather than warning. That's the handoff. What Asia does with it in the first 30 minutes of their session will set the tone for the London approach. The options structure is the tell for the overnight session. SPY is at 746.77 with the call wall sitting at 750 — three points of clear air before that ceiling asserts itself. QQQ is already pressing 740, which is its call wall. Both products are running in negative gamma, meaning the dealer hedging dynamic amplifies moves in either direction — a fade here gets messy fast, and a push through 750 on SPY or 740 on QQQ requires real volume to sustain. Neither gamma flip is in immediate dang

$Intel(INTC)$ Intel expands its Santa Clara footprint with new manufacturing and utility buildings, strengthening in-house photomask production.

$SPDR S&P 500 ETF Trust(SPY)$ Looks like Oracle is set to gain over 10%.

$SPDR S&P 500 ETF Trust(SPY)$ $Invesco QQQ(QQQ)$ My calls are looking ready to print tomorrow.